The global vascular disease devices market size was US$ 28272.71 million in 2021. The global vascular disease devices market size is forecast to reach US$ 51,804.14 million by 2030, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period from 2022 to 2030.
Vascular diseases affect the body's natural blood circulation system. Peripheral artery disease (PAD) is one type of vascular disease. There are a number of vascular diseases, including stroke, peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), carotid artery disease (CAD), arteriovenous malformation (AVM), and critical limb-threatening ischemia (CLTI). Additionally, there is deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. Infections, high blood pressure, cholesterol deposition, and vascular injury can affect the natural circulation system. Additionally, obesity, diabetes, alcohol consumption, and tobacco use are risk factors for vascular diseases.
Factors Influencing Market Growth
The increasing prevalence of vascular diseases, such as atherosclerosis, pulmonary emboli, deep vein thrombosis, and other cardiac disorders, and an increase in hospitals and surgery centers are driving the growth of the global vascular disease devices market.
The increase in cardiovascular disorders is the key factor driving the global market.
The advancement of vascular disease devices is forecast to contribute to the global market growth.
Product failures and product recalls could slow the global market growth in the forecast period.
Impact Analysis of COVID-19
COVID-19 pandemic adversely affected the global market for vascular disease devices. The lockdown caused a setback for companies, resulting in a drop in manufacturing and a reduction in patient flow. COVID-19 has also created a challenge for hospitals, resulting in the cancellation or delayed vascular surgeries. Despite this, advancements in vascular devices and better healthcare infrastructure will fuel the growth of the vascular disease devices market after the pandemic.
North America held the largest share in the vascular disease devices market in 2021 and is forecast to remain dominant during the forecast period. As a result of the prevalence of chronic diseases, the presence of key players in manufacturing & developing vascular disease devices, the growing number of hospitals & diagnostic centers, and government initiatives to treat vascular diseases.
The leading prominent companies profiled in the global vascular disease devices market are:
Boston scientific corporation
Becton Dickinson and company
B. Braun melsungen ag
Koninklijke Philips n.v.
Other Prominent Players
Scope of the Report
The global vascular disease devices market segmentation focuses on Product, End-User, and Region.
Segmentation based on Product
Stent Related Implant
Drug coated balloons
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Segmentation based on End-User
Hospitals and Cardiac Centers
Ambulatory Surgical Centers
Segmentation based on Region
Rest of Western Europe
Rest of Eastern Europe
Australia & New Zealand
Rest of Asia Pacific
Middle East & Africa (MEA)
Rest of MEA
Rest of South America